C. L. Vreede, M. C. Berkhout, A. J. Sprij, W. J. Fokkens, H. G. M

Slides:

Advertisements

Similar presentations

Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.

Advertisements

Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response Helle Krogh Johansen, Kasper.

Cheryl Cameron, Mark W. Lodes, William M. Gershan

The prevalence of “risky behaviour” in adults with cystic fibrosis

M. C. Berkhout, F. Klerx-Melis, W. J. Fokkens, M. Nuijsink, W. M. C

Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response Helle Krogh Johansen, Kasper.

E. M. Westerman, A. H. De Boer, P. P. H. Le Brun, D. J. Touw, A. C

R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J

Abaigeal D. Jackson, Christopher H. Goss Journal of Cystic Fibrosis

Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H

Megan R. Nelson, Craig R. Adamski, Audrey Tluczek

Successful treatment of cepacia syndrome

Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands R.W. Brimicombe, L. Dijkshoorn, T.J.K.

Urinary incontinence in 9��16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group W.J. Browne, C.J. Wood, M.

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study Doug L. Forrester, Alan J. Knox,

Laura Viviani, Baroukh M. Assael, Eitan Kerem

Cirrhosis and other liver disease in cystic fibrosis

Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin

John Widger, Sarath Ranganathan, Philip J. Robinson

Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.

Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation Shahid I. Sheikh, Frederick R. Long, Karen.

Controlled clinical trials in cystic fibrosis — are we doing better?

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study Christine Rønne.

Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar

D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams

Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox

Influence of digital clubbing on oxygen saturation measurements by pulse-oximetry in cystic fibrosis patients Filip Van Ginderdeuren, Karlien Van Cauwelaert,

Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis Kasper Aanaes, Lars Fledelius Rickelt, Helle Krogh Johansen,

Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn

Implementation of European standards of care for cystic fibrosis �� Control and treatment of infection J.S. Elborn, M. Hodson, C. Bertram Journal of.

The Journal of Cystic Fibrosis: Sunny perspectives

Amyloidosis in cystic fibrosis: A case series

A.H. Gifford Journal of Cystic Fibrosis

Demographics of glucose metabolism in cystic fibrosis

Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009 Yolanda P. Lillquist,

Cystic fibrosis related diabetes in an extremely young patient

Inhalation solutions — Which ones may be mixed

Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis

Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor Meredith C. Fidler, Jack Beusmans, Paul Panorchan,

E. Tschiedel, H. Grasemann, F. Ratjen Journal of Cystic Fibrosis

Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?

Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson

Nasal polyposis in lung transplant recipients with cystic fibrosis

Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients E.B. Wilms, D.J. Touw, H.G.M. Heijerman

Concentration of fractional excretion of nitric oxide (FENO): A potential airway biomarker of restored CFTR function Kavitha Kotha, Rhonda D. Szczesniak,

Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.

Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention H. White, K. Pollard, C. Etherington, I. Clifton,

Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire Joän M. Patterson, Melanie Wall, Jerica.

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

Jacob Rasmussen, Kasper Aanæs, Rikke Norling, Kim G

V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid

Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case– control study Maarten Verregghen, Harry G. Heijerman, Monique.

L. Uppaluri, S.J. England, T.F. Scanlin Journal of Cystic Fibrosis

D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher

Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study E.M. Westerman, P.P.H.

CFTR modulators and pregnancy: Our work has only just begun

‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis

L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D

Beta-lactam allergy in adults with cystic fibrosis

Cheryl Cameron, Mark W. Lodes, William M. Gershan

Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz Journal of Cystic Fibrosis

Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub

David Adeboyeku, Sandra Scott, Margaret E. Hodson

Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L

Jens U. Ponikau, MD, David A. Sherris, MD, Hirohito Kita, MD, Eugene B

R. D. Gray, M. Imrie, A. C. Boyd, D. Porteous, J. A. Innes, A. P

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience C.R.

H. White, A.M. Morton, D.G. Peckham, S.P. Conway

Presentation transcript:

Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215N C.L. Vreede, M.C. Berkhout, A.J. Sprij, W.J. Fokkens, H.G.M. Heijerman Journal of Cystic Fibrosis Volume 14, Issue 3, Pages 412-413 (May 2015) DOI: 10.1016/j.jcf.2014.07.013 Copyright © 2014 Terms and Conditions

Fig. 1 A and B: Coronal CT-sinus in 2011 (A) and 2012 (B) showing opacification of all shown paranasal sinuses (maxillary and ethmoid sinuses). C: Coronal CT-sinus in 2014, five months after treatment with ivacaftor was started, showing no opacification of all shown paranasal sinuses (maxillary and ethmoid sinuses). Journal of Cystic Fibrosis 2015 14, 412-413DOI: (10.1016/j.jcf.2014.07.013) Copyright © 2014 Terms and Conditions